drugset

drugset / Trial / NCT07104344

Study of CM355 in Patients With Systemic Lupus Erythematosus

NCT07104344 ↗

Not yet recruiting 5 enrolled Second Xiangya Hospital of Central South University

NaSingle-groupOpen-labelTreatment

Summary

This study was designed to investigate the safety and efficacy of CM355 in patients with refractory SLE.

Timeline

Start: 2025-09-25
Primary completion: 2026-04
Completion: 2026-10

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	CM355	Unknown	—	Other

Indications